Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)

被引：0
|
作者：
Liu, C. S.
Elser, C.
Huang, S.
Pond, G. R.
O'Sullivan, B.
Chen, E. X.
Waldron, J. N.
Goldstein, D.
Siu, L. L.
Kim, J.
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] Everest Clin Res Serv, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6052
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Compliance of elderly head and neck squamous cell carcinoma (HNSCC) patients (pts) with concurrent chemoradiotherapy (CRT) in cetuximab versus cisplatin.
    Kazan, Eyad
    Kleihneny, Tiffanie
    Sakek, Nacera
    Thomas, Alice
    Milian, Lucia
    Edel, Magali
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Concurrent chemoradiation with low dose weekly cisplatin in stage IV head and neck squamous cell carcinoma
    Kang, M.
    Song, H.
    Kang, J.
    Woo, S.
    Park, J.
    Kim, J.
    Jeong, B.
    Kang, K.
    Chai, G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S770 - S770
  • [43] eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT)
    Haddad, Robert I.
    Ruscica, Dario
    Visa, Alexandra
    Li, Xia
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Treatment Related Risk Factors for Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    No, H. J.
    Tam, M. M.
    Wu, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1214 - 1214
  • [45] Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Furqan, Muhammad
    Snyders, Travis P.
    Saqlain, Mohammed U.
    Mott, Sarah L.
    Laux, Douglas
    Snow, Anthony
    Anderson, Carryn M.
    Watkins, John M.
    Clamon, Gerald H.
    CANCER MEDICINE, 2019, 8 (06): : 2730 - 2739
  • [46] Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients
    Ana Maria Castro Ferreira
    João Maurício Carrasco Altemani
    Ligia Traldi Macedo
    Gustavo Jacob Lourenço
    Carmen Silvia Passos Lima
    Scientific Reports, 13
  • [47] Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients
    Ferreira, Ana Maria Castro
    Altemani, Joo Mauricio Carrasco
    Macedo, Ligia Traldi
    Lourenco, Gustavo Jacob
    Lima, Carmen Silvia Passos
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Pembrolizumab plus chemoradiation therapy for locally advanced head and neck squamous cell carcinoma (HNSCC): KEYNOTE-412
    Tahara, Makoto
    Machiels, Jean-Pascal
    Tao, Yungan
    Burtness, Barbara
    Rischin, Danny
    Alves, Gustavo V.
    Lima, Iane Pinto Figueiredo
    Hughes, Brett G. M.
    Pointreau, Yoann
    Aksoy, Sercan
    Laban, Simon
    Greil, Richard
    Burian, Martin
    Hetnal, Marcin
    Licitra, Lisa
    Swaby, Ramona
    Zhang, Yayan
    Bidadi, Behzad
    Siu, Lillian L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1380 - S1380
  • [49] Gemcitabine versus cisplatin concurrent with radiation therapy in locally advanced head and neck squamous cell carcinoma
    Mostafa, Magda
    Atif, Hesham
    Fawzy, Mahmoud
    Sakr, Amr Yehia
    Alashwah, Ahmed
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH CAPECITABINE AND CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Gupta, S.
    Khan, H.
    Barik, S.
    Negi, M. P. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S2 - S2
12345